Synapse Open Synapse
Patents & IP

Beijing to tighten biotech exports as big-ticket Chinese pharma dealmaking soars

IAM ·

Proposed export regime for cell and gene therapy, siRNA platform technologies allows IP licensing while keeping ownership in China

Latest from IAM